Sio Capital Management, LLC Cel Sci Corp Put Options Transaction History

Sio Capital Management, LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2021 Aug 16, 2021	SELL	$8.68 - $27.49 $6.04 Million - $19.1 Million	-695,700 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$12.0 - $27.64 $17.1 Million - $39.4 Million	-1,424,900 Reduced 67.19%	695,700 $10.6 Million
Q4 2020 Feb 16, 2021	BUY	$11.05 - $16.62 $10.2 Million - $15.4 Million	924,900 Added 77.35%	2,120,600 $24.7 Million
Q3 2020 Nov 16, 2020	BUY	$11.69 - $14.54 $10.1 Million - $12.6 Million	864,800 Added 261.35%	1,195,700 $15.2 Million
Q2 2020 Aug 14, 2020	SELL	$9.75 - $17.6 $9.48 Million - $17.1 Million	-972,200 Reduced 74.61%	330,900 $4.94 Million
Q1 2020 May 15, 2020	SELL	$7.54 - $17.05 $1.69 Million - $3.83 Million	-224,500 Reduced 14.7%	1,303,100 $15 Million
Q4 2019 Feb 14, 2020	BUY	$6.71 - $9.55 $5.58 Million - $7.95 Million	832,000 Added 119.61%	1,527,600 $14 Million
Q3 2019 Nov 14, 2019	BUY	$6.0 - $9.6 $4.17 Million - $6.68 Million	695,600 New	695,600 $6.22 Million

27.1K

150K

Ticker CVM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,367,500
Market Cap $26.9M
Description
CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sio Capital Management, LLC with notifications on news.